Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

17

Revenue 2017

Allergan

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Allergan's 2013 CNS (central nervous system) sales performance.

AbbVie to acquire Allergan for $63bn

AbbVie to acquire Allergan for $63bn Key to the AbbVie-Allergan merger will be the cutbacks made across the companies, which have been laid out today. ... far from a given, especially as Allergan brings lots of baggage, including a sprawling business portfolio and debt of around $24bn.

GSK joins forces with Doudna’s CRISPR lab

GSK joins forces with Doudna’s CRISPR lab The first ever FDA-approved clinical trial of an in vivo CRISPR-based therapy is expected to get under way very soon; Editas and Allergan plan to begin the trial of

Amgen buys Danish partner Nuevolution for $167m

Amgen buys Danish partner Nuevolution for $167m It’s worth noting that RORγt inhibitors have a somewhat chequered history , with AstraZeneca and Allergan both having recent failed programmes in this category (AZD0284 and AGN-242428, respectively).

Pfizer’s alliance with Sosei Heptares bears first fruit

Pfizer’s alliance with Sosei Heptares bears first fruit Pfizer is just one of Sosei Heptares’ big pharma partners, and the company has also attracted sizeable collaborations with AstraZeneca, Allergan, Novartis, and Daiichi-Sankyo.

CHMP nod for Alexion, GSK drugs, revocation for Lartruvo

CHMP nod for Alexion, GSK drugs, revocation for Lartruvo Nuceiva (botulinum toxin type a), a facial filler for vertical lines between the eyebrows, a new rival for Allergan’s Botox.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...

Infographics